WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT

Not Applicable

Terminated

Conditions: Embryo Transfer
Assisted Reproductive Technology
Antibiotic Prophylaxis

Interventions: Other: Withholding antibiotic prophylaxis

First Posted Date: 2017-12-29

Last Posted Date: 2020-08-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT03386227

Locations: 🇺🇸
Washington University Reproductive Endocrinology, Saint Louis, Missouri, United States

Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis

Phase 1

Terminated

Conditions: Myelofibroses

Interventions: Drug: Pevonedistat
Drug: Ruxolitinib
Procedure: Peripheral blood draw
Procedure: Skin biopsy

First Posted Date: 2017-12-29

Last Posted Date: 2022-01-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT03386214

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo

Not Applicable

Active, not recruiting

Conditions: Coronary Artery Disease
Smoking Cessation

Interventions: Other: genotype-guided therapy
Drug: Nicotine patch
Behavioral: Smoking cessation counseling

First Posted Date: 2017-12-26

Last Posted Date: 2021-11-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT03383224

Locations: 🇺🇸
Barnes Hospital, Saint Louis, Missouri, United States

Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)

Completed

Conditions: Anemia, Sickle Cell

Interventions: Behavioral: SCDIC interventions

First Posted Date: 2017-12-21

Last Posted Date: 2024-05-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT03380351

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Hospital Avoidance Strategies for ABSSSI

Phase 4

Terminated

Conditions: Skin Infection

Interventions: Drug: Dalbavancin

First Posted Date: 2017-12-14

Last Posted Date: 2022-12-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 11

Registration Number: NCT03372941

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

Conditions: Merkel Cell Carcinoma
Skin Cancer
Squamous Cell Carcinoma of the Skin
Autoimmunity
Melanoma
Basal Cell Carcinoma

First Posted Date: 2017-12-12

Last Posted Date: 2021-01-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 125

Registration Number: NCT03370861

Locations: 🇺🇸
Barnes-Jewish Hosptial, Saint Louis, Missouri, United States

Fecal Microbiota Transplantation (FMT) for MDRO UTI

Phase 1

Completed

Conditions: Urinary Tract Infections

Interventions: Drug: Fecal microbiota transplant

First Posted Date: 2017-12-11

Last Posted Date: 2022-03-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1

Registration Number: NCT03367910

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Nitrous Oxide Treatment for Tinnitus

Phase 4

Completed

Conditions: Tinnitus

Interventions: Drug: Nitrous oxide gas for inhalation
Drug: Placebo gas for inhalation

First Posted Date: 2017-12-07

Last Posted Date: 2018-12-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT03365011

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

Completed

Conditions: Lymphatic Filariases

Interventions: Drug: 3 drug dose - IDA
Drug: 2 drug dose - DA

First Posted Date: 2017-11-24

Last Posted Date: 2020-12-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20092

Registration Number: NCT03352206

Locations: 🇮🇳
Vector Control Research Centre, Puducherry, India
🇮🇩
Universitas Indonesia, Jakarta, Indonesia
🇭🇹
Ministere de la Sante Publique et de la Population, Port-au-Prince, Haiti

and more 2 locations

Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics

Recruiting

Conditions: Diabetes Mellitus, Type 2
Hypertension
Vitamin D Deficiency

Interventions: Diagnostic Test: Blood draw

First Posted Date: 2017-11-20

Last Posted Date: 2024-07-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT03348280

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Barnes-Jewish & Washington University Diabetes Center, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy